AbbVie: Updates in AI-driven OCT Biomarker Analysis to Optimise Treatment for DME and RVO

AbbVie: Personalised Treatment for the Right Patient at the Right Time: Advances in AI-driven optimization of outcomes in DME and RVO

Location: Room Maillot
Date & Time: Saturday, 6th September, 13:00 – 14:00 CEST
Chairperson(s): L. Kodjikian, FRANCE

Speakers:

Presentations:

L. Kodjikian, FRANCE

13:00 Introduction and symposium objectives

A. Couturier, FRANCE
P. Udaondo, SPAIN

13:03 Inflammatory OCT profiles and the expanding role of AI

L. Cehofski, DENMARK

13:18 Proteomics and AI-driven OCT Biomarker analysis to understand inflammation in retinal vascular diseases

L. Kodjikian, FRANCE

13:33 Determining the optimal treatment regimen in macular oedema: A path to improved outcomes

All Speakers

13:48 Panel discussion with Q&A

L. Kodjikian, FRANCE

13:57 Summary and close

Back to Main Programme

www.euretina.org is the only official website of the European Society of Retina Specialists.

Please be wary of websites, emails from third-party agencies using similar names, addresses or branding and purporting to represent Euretina.

This includes websites or companies offering Congress registration, hotel accommodation or travel services while claiming to be affiliated with Euretina.

Should you use any website other than www.euretina.org, or book accommodation through an unauthorised third-party site, you may be charged significantly more than the official registration fee, your hotel booking may not be valid, and you may not be registered for the event at all.

If you have any questions in relation to registration or accommodation for the Congress, these should only be directed to [email protected].

AbbVie: Personalised Treatment for the Right Patient at the Right Time: Advances in AI-driven optimization of outcomes in DME and RVO

Beware of fraudulent websites, emails and hotel booking offers